[The state of psychopharmacotherapy in geriatrics 2].
D000183:Actihaemyl / Q000627:therapeutic use; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use; D001537:Bencyclane / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D003693:Delirium / Q000188:drug therapy; D003704:Dementia / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy; D003911:Dextrans / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D009567:Nitrazepam / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D010259:Paranoid Disorders / Q000188:drug therapy; D011398:Promethazine / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014291:Trimeprazine / Q000627:therapeutic use
D003911:Dextrans; D011619:Psychotropic Drugs; D000639:Amitriptyline; D000183:Actihaemyl; D003009:Clorazepate Dipotassium; D001537:Bencyclane; D014291:Trimeprazine; D009567:Nitrazepam; D011398:Promethazine; D005947:Glucose; D007099:Imipramine; D003975:Diazepam
Stand der Psychopharmakotherapie in der Geriatrie Teil 2.